Progress in the clinical application and correlation between glucose transporter-1 and / 生物医学工程学杂志
Journal of Biomedical Engineering
;
(6): 399-404, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-879290
ABSTRACT
Because of the unobvious early symptoms and low 5-year survival rate, the early diagnosis and treatment is of great significance for patients with non-small cell lung cancer. Glucose transporter-1 is the most widely distributed glucose transporters in various tissue cells in the human body, whose expression in non-small cell lung cancer is closely related to the histological types, lymph node metastasis, degree of differentiation, progression and prognosis.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Radiopharmaceuticals
/
Fluorodeoxyglucose F18
/
Positron-Emission Tomography
/
Glucose Transport Proteins, Facilitative
/
Glucose Transporter Type 1
/
Positron Emission Tomography Computed Tomography
/
Lung Neoplasms
Type of study:
Screening study
Limits:
Humans
Language:
Chinese
Journal:
Journal of Biomedical Engineering
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS